European equities traded in the US as American depositary receipts kicked off the week tracking higher late Monday morning, rising 0.44% to 1,432.38 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by telecommunications operator VEON (VEON) and software firm SAP (SAP), which rose 2.7% and 1.1%, respectively. They were followed by pharmaceutical company Sanofi (SNY) and telecommunications company Nokia (NOK), which were up 0.8% and 0.6%, respectively.
The decliners from continental Europe were led by biopharmaceutical company Genfit (GNFT) and internet browser company Opera (OPRA), which fell 3.1% and 2.2%, respectively. They were followed by biopharmaceutical company Grifols (GRFS) and biotech firm Evaxion Biotech (EVAX), which lost 1.8% and 1.1%, respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical companies Biodexa Pharmaceuticals (BDRX) and Verona Pharma (VRNA), which increased 2.3% and 1.6%, respectively. They were followed by insurance company Prudential (PUK) and biopharmaceutical company Amarin (AMRN), which were up 0.7%, each.
The decliners from the UK and Ireland were led by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company NuCana (NCNA), which dropped 16% and 6.2%, respectively. They were followed by biopharmaceutical company Adaptimmune Therapeutics (ADAP) and pharmaceutical company Silence Therapeutics (SLN), which were down 2.2% and 1.9%, respectively.
Comments